Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Eldar Hochman"'
Autor:
Amir Krivoy, Roy Onn, Yael Vilner, Eldar Hochman, Shira Weizman, Amir Paz, Shmuel Hess, Roi Sagy, Shiri Kimhi-Nesher, Ehud Kalter, Tal Friedman, Zvi Friedman, Gil Bormant, Sharon Trommer, Avi Valevski, Abraham Weizman
Publikováno v:
EBioMedicine, Vol 26, Iss C, Pp 138-145 (2017)
Background: While accumulating evidence suggests that vitamin D deficiency may be involved in the risk to develop schizophrenia and its outcome, there are no studies on vitamin D supplementation in this context. We sought to assess the effect of vita
Externí odkaz:
https://doaj.org/article/944143d687cd49e69af5499f4226db81
Autor:
Eldar Hochman, Michal Taler, Reut Flug, Shay Gur, Shira Dar, Gil Bormant, Dori Blattberg, Uri Nitzan, Amir Krivoy, Abraham Weizman
Publikováno v:
Brain, Behavior, and Immunity. 109:162-167
Autor:
Eldar Hochman, Becca Feldman, Abraham Weizman, Amir Krivoy, Shay Gur, Eran Barzilay, Hagit Gabay, Ohad Levinkron-Fisch, Gabriella Lawrence
Publikováno v:
Journal of affective disorders.
While anemia during pregnancy has been linked to increased postpartum depression (PPD) risk, longitudinal studies on the association between gestational hemodilution, represented by decreased hematocrit (Hct) during the transition from the 1st to 2nd
Autor:
Joseph Levy, Abraham Weizman, Shay Gur, Amir Krivoy, Gabriella M. Lawrence, Hagit Gabay, Ohad Levinkron, Eldar Hochman, Eran Barzilay, Becca Feldman
Publikováno v:
Depression and Anxiety. 38:400-411
Background Currently, postpartum depression (PPD) screening is mainly based on self-report symptom-based assessment, with lack of an objective, integrative tool which identifies women at increased risk, before the emergent of PPD. We developed and va
Autor:
Ramona Aronovich, Shira Dar, Shay Henry Hornfeld, Efrat Sasson, Eldar Hochman, Michal Taler, Abraham Weizman
Publikováno v:
Bipolar Disorders. 23:55-65
Objectives Recent evidence has associated mood disorders with blood-brain barrier (BBB)/ neurovascular unit (NVU) dysfunction, and reduction in blood vessels coverage by the water channel aquaporin-4 (AQP4) immunoreactive astrocytes. Lithium is an es
Autor:
Eldar Hochman, Livnat Brill, Dori Blattberg, Gil Bormant, Adi Vaknin-Dembinsky, Abraham Weizman, Michal Taler, Uri Nitzan, Shay Gur, Amir Krivoy
Publikováno v:
Brain, behavior, and immunity. 88
Aquaporin-4 (AQP4), an astrocyte water channel protein, is the target antigen of serum immunoglobulin G (IgG) autoantibody in neuromyelitis optica spectrum disorders (NMOsd), a group of inflammatory, demyelinating diseases of the central nervous syst
Autor:
Gal Shoval, Abraham Weizman, Fiona Gaughran, Shay Henry Hornfeld, Joshua Satz, Michal Taler, Amir Krivoy, Eldar Hochman, Lior Bar
Publikováno v:
International clinical psychopharmacology. 35(4)
Low levels of vitamin D are prevalent among patients with schizophrenia and have been linked to the risk and outcome of the disorder. Vitamin D has a regulatory effect on the inflammatory system, which is dysfunctional in schizophrenia. We investigat
Publikováno v:
European Neuropsychopharmacology. 28:353-360
Although antidepressants (ADs) are widely used in bipolar depression, there is weak evidence for their effectiveness and safety in this condition. Furthermore, there is a paucity of studies on the risk-benefit ratio of AD maintenance treatment in bip
Autor:
Abraham Weizman, Michal Taler, Amir Krivoy, Sarah Hollander, Yael Vilner, Mirjana Selaković, Kyra-Verena Sendt, Eldar Hochman
Publikováno v:
Schizophrenia Research. 192:226-231
Clozapine is the only available therapy for about 30% of schizophrenia patients otherwise refractory to antipsychotics. Unfortunately, the mechanism of action of the drug is still unknown and there are no biomarkers that can predict a positive respon
Autor:
Zvi Friedman, Shira Weizman, Sharon Trommer, Yael Vilner, Eldar Hochman, Ehud Kalter, Avi Valevski, Abraham Weizman, Roy Onn, Amir Krivoy, Tal Friedman, Shmuel Hess, Shiri Kimhi-Nesher, Gil Bormant, Roi Sagy, Amir Paz
Publikováno v:
EBioMedicine
EBioMedicine, Vol 26, Iss C, Pp 138-145 (2017)
Krivoy, A, Onn, R, Vilner, Y, Hochman, E, Weizman, S, Paz, A, Hess, S, Sagy, R, Kimhi-Nesher, S, Kalter, E, Friedman, T, Friedman, Z, Bormant, G, Trommer, S, Valevski, A & Weizman, A 2017, ' Vitamin D Supplementation in Chronic Schizophrenia Patients Treated with Clozapine : A Randomized, Double-Blind, Placebo-controlled Clinical Trial ', EBioMedicine . https://doi.org/10.1016/j.ebiom.2017.11.027
EBioMedicine, Vol 26, Iss C, Pp 138-145 (2017)
Krivoy, A, Onn, R, Vilner, Y, Hochman, E, Weizman, S, Paz, A, Hess, S, Sagy, R, Kimhi-Nesher, S, Kalter, E, Friedman, T, Friedman, Z, Bormant, G, Trommer, S, Valevski, A & Weizman, A 2017, ' Vitamin D Supplementation in Chronic Schizophrenia Patients Treated with Clozapine : A Randomized, Double-Blind, Placebo-controlled Clinical Trial ', EBioMedicine . https://doi.org/10.1016/j.ebiom.2017.11.027
Background While accumulating evidence suggests that vitamin D deficiency may be involved in the risk to develop schizophrenia and its outcome, there are no studies on vitamin D supplementation in this context. We sought to assess the effect of vitam